Epi-On Corneal Crosslinking for Keratoconus (NCT03245853) | Clinical Trial Compass
CompletedPhase 4
Epi-On Corneal Crosslinking for Keratoconus
United States20 participantsStarted 2017-07-18
Plain-language summary
Epithelium-On Corneal Crosslinking for Keratoconus.
Who can participate
Age range14 Years – 40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 12 to 40 years of age, having a diagnosis of keratoconus, signed written informed consent, willingness and ability to comply with schedule for follow-up visits
Exclusion Criteria:
* Previous ocular condition (other than refractive error) in the eye(s) to be treated that may predispose the eye for future complications (herpes simplex/zoster, recurrent corneal erosion syndrome, corneal melt, corneal dystrophy, etc.) Pregnancy, intent to become pregnant, or lactation during study. Corneal pachymetry \<350 microns at the thinnest point measured by Pentacam in the eye(s) to be treated.
Nystagmus or any other condition that would prevent steady gaze. Other systemic condition that in the investigator's opinion would not allow the patient to be a good candidate for the study.